Rigel Pharmaceuticals, Inc. (RIGL)
39.65
-6.06
(-13.26%)
USD |
NASDAQ |
Nov 06, 16:00
39.60
-0.05
(-0.13%)
After-Hours: 20:00
Rigel Pharmaceuticals Price : 39.65 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 41.11 | 41.67 | 37.60 | 39.65 | 759188.0 |
| Nov 05, 2026 | 51.53 | 51.53 | 44.99 | 45.71 | 551003.0 |
| Nov 04, 2026 | 50.57 | 51.74 | 49.22 | 51.29 | 288613.0 |
| Nov 03, 2026 | 50.44 | 51.29 | 46.88 | 48.86 | 286979.0 |
| Nov 02, 2026 | 51.33 | 51.84 | 50.00 | 50.53 | 136046.0 |
| Oct 30, 2026 | 51.80 | 52.60 | 50.67 | 51.31 | 174405.0 |
| Oct 29, 2026 | 51.17 | 51.60 | 50.24 | 51.45 | 159560.0 |
| Oct 28, 2026 | 50.26 | 51.36 | 50.06 | 50.74 | 226331.0 |
| Oct 27, 2026 | 50.09 | 50.70 | 49.54 | 50.55 | 133105.0 |
| Oct 26, 2026 | 48.63 | 50.00 | 48.32 | 49.91 | 196564.0 |
| Oct 23, 2026 | 48.48 | 48.48 | 47.47 | 48.13 | 119261.0 |
| Oct 22, 2026 | 48.97 | 49.94 | 48.55 | 48.86 | 152640.0 |
| Oct 21, 2026 | 47.64 | 49.01 | 47.64 | 48.88 | 195892.0 |
| Oct 20, 2026 | 46.73 | 48.16 | 46.73 | 48.11 | 366264.0 |
| Oct 19, 2026 | 46.39 | 47.38 | 45.48 | 46.72 | 318414.0 |
| Oct 16, 2026 | 47.58 | 47.58 | 45.68 | 45.97 | 141432.0 |
| Oct 15, 2026 | 47.01 | 48.52 | 47.01 | 47.25 | 167855.0 |
| Oct 14, 2026 | 46.82 | 47.99 | 46.37 | 46.82 | 160105.0 |
| Oct 13, 2026 | 48.70 | 48.87 | 47.04 | 47.14 | 133999.0 |
| Oct 12, 2026 | 49.22 | 49.89 | 48.54 | 48.81 | 162529.0 |
| Oct 09, 2026 | 48.60 | 50.49 | 48.60 | 49.08 | 279363.0 |
| Oct 08, 2026 | 47.33 | 48.89 | 46.56 | 48.72 | 216848.0 |
| Oct 07, 2026 | 45.64 | 48.15 | 45.22 | 47.99 | 232585.0 |
| Oct 06, 2026 | 48.18 | 48.18 | 45.93 | 46.11 | 202599.0 |
| Oct 05, 2026 | 47.02 | 48.83 | 46.93 | 47.79 | 391628.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cytokinetics, Inc. | 53.69 |
| Inovio Pharmaceuticals, Inc. | 1.215 |
| United Therapeutics Corp. | 562.02 |
| Verastem, Inc. | 8.41 |
| Marker Therapeutics, Inc. | 0.8928 |
Price Related Metrics
| PE Ratio | 2.429 |
| PS Ratio | 2.801 |
| PEG Ratio | 0.0121 |
| Price to Book Value | 1.739 |
| Price to Free Cash Flow | 85.74 |
| Earnings Yield | 41.17% |
| Market Cap | 739.63M |
| PEGY Ratio | 0.0121 |
| Operating PE Ratio | 8.905 |
| Normalized PE Ratio | 2.428 |